CNNA (Cann American) Shares Outstanding (EOP): 0.00 Mil (As of Aug. 2012)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cann American Shares Outstanding (EOP)?

Cann American CNNA +16.95% Shares Outstanding (EOP) is 0.00 Mil as of Aug. 2012.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Cann American's shares outstanding for the quarter that ended in Aug. 2012 was 0.00 Mil.

Cann American's quarterly shares outstanding stayed the same from May. 2012 (0.00 Mil) to Aug. 2012 (0.00 Mil).

Cann American's annual shares outstanding stayed the same from Feb. 2011 (0.00 Mil) to Feb. 2012 (0.00 Mil).


Cann American  (OTCPK:CNNA) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Cann American Shares Outstanding (EOP) Related Terms


Cann American Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Cann American's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cann American Shares Outstanding (EOP) Chart

Cann American Annual Data
Trend Feb08 Feb09 Feb10 Feb11 Feb12
Shares Outstanding (EOP)
0.00 0.00 0.00 0.00 0.00

Cann American Quarterly Data
Nov07 Feb08 May08 Aug08 Nov08 Feb09 May09 Aug09 Nov09 Feb10 May10 Aug10 Nov10 Feb11 May11 Aug11 Nov11 Feb12 May12 Aug12
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CNNA vs GLUC, HISP, FTLF: Shares Outstanding (EOP) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cann American's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cann American Shares Outstanding (EOP) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cann American's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Cann American's Shares Outstanding (EOP) falls into.



Cann American Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 0.00 Mil mean?
Cann American (CNNA) has a Shares Outstanding (EOP) of 0.00 Mil as of Aug. 2012. The total shares a company has outstanding, at period-end. View historical data on Cann American and its competitors.
Is Cann American's Shares Outstanding (EOP) too high?
Cann American's current Shares Outstanding (EOP) is 0.00 Mil.
How does Cann American's Shares Outstanding (EOP) compare to GLUC and HISP?
Cann American's Shares Outstanding (EOP) of 0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Drug Manufacturers company?
A good Shares Outstanding (EOP) depends on the Drug Manufacturers industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Cann American and its competitors. Cann American's current Shares Outstanding (EOP) is 0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cann American stock overvalued right now?
Cann American (CNNA) has a current Shares Outstanding (EOP) of 0.00 Mil. The current Shares Outstanding (EOP) is 0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Cann American (CNNA), the current Shares Outstanding (EOP) is 0.00 Mil as of Aug. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cann American Business Description

Address 320 Santana Drive, Suite C, Cloverdale, CA, USA, 95425
Cann American Corp is engaged in developing assets in legal cannabis and hemp industries. It is focused on consulting, infrastructure developming assets, product marketing and strategic acquisitions within the legal cannabis and hemp industries.